These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 17935544)

  • 1. Factors influencing the formation of small dense low-density lipoprotein particles in dependence on the presence of the metabolic syndrome and on the degree of glucose intolerance.
    Julius U; Dittrich M; Pietzsch J
    Int J Clin Pract; 2007 Nov; 61(11):1798-804. PubMed ID: 17935544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intensive insulin therapy reduces small dense low-density lipoprotein particles in patients with type 2 diabetes mellitus: relationship to triglyceride-rich lipoprotein subspecies.
    Hayashi T; Hirano T; Yamamoto T; Ito Y; Adachi M
    Metabolism; 2006 Jul; 55(7):879-84. PubMed ID: 16784958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concentration and relative distribution of low-density lipoprotein subfractions in patients with metabolic syndrome defined according to the National Cholesterol Education Program criteria.
    Gazi I; Tsimihodimos V; Filippatos T; Bairaktari E; Tselepis AD; Elisaf M
    Metabolism; 2006 Jul; 55(7):885-91. PubMed ID: 16784959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
    Sasaki J; Ikeda Y; Kuribayashi T; Kajiwara K; Biro S; Yamamoto K; Ageta M; Kobori S; Saikawa T; Otonari T; Kono S
    Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small dense LDL particles and metabolic syndrome in a sample of middle-aged women. Findings from Progetto Atena.
    Gentile M; Panico S; Jossa F; Mattiello A; Ubaldi S; Marotta G; Pauciullo P; Rubba P
    Clin Chim Acta; 2008 Feb; 388(1-2):179-83. PubMed ID: 18035055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ethnic differences in the formation of small LDL particles in Asians: a comparison of Koreans, Japanese and Mongolians.
    Anuurad E; Shiwaku K; Enkhmaa B; Nogi A; Kitajima K; Yamasaki M; Yamane Y
    Eur J Clin Invest; 2004 Nov; 34(11):738-46. PubMed ID: 15530146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of the Friedewald formula for the determination of low-density lipoprotein cholesterol compared with beta-quantification in a large population.
    Tremblay AJ; Morrissette H; Gagné JM; Bergeron J; Gagné C; Couture P
    Clin Biochem; 2004 Sep; 37(9):785-90. PubMed ID: 15329317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of a low-calorie diet associated with weight loss on lipoprotein-associated phospholipase A2 (Lp-PLA2) activity in healthy obese women.
    Tzotzas T; Filippatos TD; Triantos A; Bruckert E; Tselepis AD; Kiortsis DN
    Nutr Metab Cardiovasc Dis; 2008 Sep; 18(7):477-82. PubMed ID: 17928209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-density lipoprotein (LDL) particle size in healthy prepubertal children: the STRIP study.
    Kaitosaari T; Rönnemaa T; Viikari J; Leino A; Jokinen E; Simell O
    Acta Paediatr; 2006 Dec; 95(12):1668-73. PubMed ID: 17129981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of ezetimibe/simvastatin on lipoprotein subfractions in patients with primary hypercholesterolemia: an exploratory analysis of archived samples using two commercially available techniques.
    Ose L; Reyes R; Johnson-Levonas AO; Sapre A; Tribble DL; Musliner T
    Clin Ther; 2007 Nov; 29(11):2419-32. PubMed ID: 18158082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Should we measure routinely the LDL peak particle size?
    Rizzo M; Berneis K
    Int J Cardiol; 2006 Feb; 107(2):166-70. PubMed ID: 16412793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prevalence of impaired glucose metabolism in Hispanics with two or more risk factors for metabolic syndrome in the primary care setting.
    Neira CP; Hartig M; Cowan PA; Velasquez-Mieyer PA
    J Am Acad Nurse Pract; 2009 Mar; 21(3):173-8. PubMed ID: 19302694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small dense low-density lipoproteins and associated risk factors in patients with stroke.
    Zhao CX; Cui YH; Fan Q; Wang PH; Hui R; Cianflone K; Wang DW
    Cerebrovasc Dis; 2009; 27(1):99-104. PubMed ID: 19033685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small, dense low-density-lipoproteins and the metabolic syndrome.
    Rizzo M; Berneis K
    Diabetes Metab Res Rev; 2007 Jan; 23(1):14-20. PubMed ID: 17080469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of high-carbohydrate/low-fat diet on serum lipid ratios in healthy young subjects].
    Gan CF; Gong RR; Lin J; Li ZK; Tang H; Huang X; Li RH; Fang DZ
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Mar; 39(2):267-71, 275. PubMed ID: 18630700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Postprandial changes of blood lipid after ordinary Chinese diet and the influencing factors thereof].
    Fu ZF; Liu ML
    Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(4):260-2. PubMed ID: 19552844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear magnetic resonance-determined lipoprotein abnormalities in nonhuman primates with the metabolic syndrome and type 2 diabetes mellitus.
    Ding SY; Tigno XT; Hansen BC
    Metabolism; 2007 Jun; 56(6):838-46. PubMed ID: 17512318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atherogenic lipoprotein phenotype and LDL size and subclasses in women with gestational diabetes.
    Rizzo M; Berneis K; Altinova AE; Toruner FB; Akturk M; Ayvaz G; Rini GB; Spinas GA; Arslan M
    Diabet Med; 2008 Dec; 25(12):1406-11. PubMed ID: 19046238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circadian rhythm of serum concentration of small dense low-density lipoprotein cholesterol.
    Ogita K; Ai M; Tanaka A; Ito Y; Hirano T; Yoshino G; Shimokado K
    Clin Chim Acta; 2007 Feb; 376(1-2):96-100. PubMed ID: 16950238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Baseline triglyceride levels and insulin sensitivity are major determinants of the increase of LDL particle size and buoyancy induced by rosuvastatin treatment in patients with primary hyperlipidemia.
    Kostapanos MS; Milionis HJ; Lagos KG; Rizos CB; Tselepis AD; Elisaf MS
    Eur J Pharmacol; 2008 Aug; 590(1-3):327-32. PubMed ID: 18585701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.